Showing results (101-110 of 122) with videos related to
Sort By:
Pageof 13
International Journal of Hematology|May 12, 2026
T-cell fitness, metabolic tumor volume, and serum LDH levels are associated with response to axicabtagene ciloleucelRisa Nishiyama, Anna Hiratsuka, Tetsuro Ochi, et al.Translational Lung Cancer Research|March 25, 2020
Low-dose CT lung cancer screening in never-smokers and smokers: results of an eight-year observational studyRyutaro Kakinuma, Yukio Muramatsu, Hisao Asamura, et al.Carcinogenesis|June 27, 2019
Establishment of permutation for cancer risk estimation in the urothelium based on genome-wide DNA methylation analysisKoji Tsumura, Eri Arai, Ying Tian, et al.International Journal of Clinical Oncology|April 12, 2026
Real-world outcomes of chimeric antigen receptor T-cell therapy with pembrolizumab as holding and/or bridging therapy in relapsed/refractory primary mediastinal large B-cell lymphomaRisa Nishiyama, Shinichi Makita, Anna Hiratsuka, et al.Annals of Hematology|December 9, 2016
Prognosis of patients with peripheral T cell lymphoma who achieve complete response after CHOP/CHOP-like chemotherapy without autologous stem cell transplantation as an initial treatmentHideaki Kitahara, Dai Maruyama, Akiko Miyagi Maeshima, et al.Cytotherapy|October 11, 2015
Donor lymphocytes expressing the herpes simplex virus thymidine kinase suicide gene: detailed immunological function following add-back after haplo-identical transplantationHisayoshi Hashimoto, Shigehisa Kitano, Shizuka Yamagata, et al.Cancers|June 27, 2024
Immunohistochemical Profiling of SSTR2 and HIF-2α with the Tumor Microenvironment in Pheochromocytoma and ParagangliomaMasaki Uchihara, Akiyo Tanabe, Yuki Kojima, et al.Cancer Medicine|June 9, 2021
Clinicopathological analysis of primary refractory diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone chemoimmunotherapyTomotaka Suzuki, Dai Maruyama, Akiko Miyagi-Maeshima, et al.European Journal of Haematology|September 6, 2019
Association of CD204+ macrophages with poor outcomes of malignant lymphomas not in remission treated by allogeneic HCTAkihisa Kawajiri, Shigehisa Kitano, Akiko Miyagi Maeshima, et al.European Journal of Haematology|October 24, 2020
The role of local radiotherapy following rituximab-containing chemotherapy in patients with transformed indolent B-cell lymphomaKenji Nozaki, Dai Maruyama, Akiko Miyagi Maeshima, et al.Pageof 13